ラクターゼ市場の成長・規模・動向分析：由来・用途・形態別 - 地域別の展望・競合戦略・セグメント予測 (～2034年)

世界のラクターゼの市場規模は、予測期間中はCAGR 5.33%で推移し、2034年には4億358万に達すると予測されています。

ラクターゼは、人間やその他の動物の胃に存在する酵素で、乳糖をグルコースとガラクトースに分解します。乳糖は乳製品に含まれており、ラクターゼはその分解を助けます。一定の人々はラクターゼ酵素が不足しているため、乳製品に含まれる乳糖を消化することができません。この問題に対応するため、乳製品にラクターゼを添加したり、ラクターゼのサプリメントを摂取することで、摂取前に乳糖を分解できるようにしています。

当レポートでは、世界のラクターゼの市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

• 促進要因、制約要因、機会要因、課題の分析

第5章 市場変数と見通し

• SWOT分析
• PESTEL分析
• ポーターのファイブフォース分析
• ヒートマップ分析

第6章 競合情勢

• 製造拠点の分布・販売エリア・製品タイプ
• M&A・提携・製品発売・協力

第7章 世界のラクターゼ市場：由来別

• 菌類
• 酵母
• 細菌

第8章 世界のラクターゼ市場：用途別

• 食品・飲料
  • 牛乳
  • チーズ
  • ヨーグルト
  • その他
• 栄養補助食品
• 医薬品

第9章 世界のラクターゼ市場：形態別

• 粉末
• 液体

第10章 世界のラクターゼ市場

• 市場規模・市場シェア

第11章 世界のラクターゼ市場：地域別

• アジア太平洋
  • オーストラリア
  • 中国
  • インド
  • 日本
  • 韓国
  • その他
• 欧州
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • 英国
  • その他
• 中東・アフリカ
  • サウジアラビア
  • UAE
  • カタール
  • 南アフリカ
  • エジプト
  • モロッコ
  • ナイジェリア
  • その他
• 北米
  • カナダ
  • メキシコ
  • 米国
• ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • その他

第12章 企業プロファイル

• Mitushi Biopharma
• Rajvi Enterprise
• Infinita Biotech Pvt. Ltd
• Aumgene Biosciences
• DuPont
• Antozyme Biotech Pvt. Ltd
• Novact Corp
• Biolaxi Corp
• Creative Enzymes
• Nature BioScience Pvt. Ltd
• ENMEX
• Advanced Enzyme Technologies
• Amano Enzyme Inc
• Senson
• Merck KGaA
• その他

第13章 総論

第14章 略語一覧

第15章 参考リンク

Lactase Market Introduction and Overview

According to SPER market research, 'Global Lactase Market Size- By Source, By Application, By Form - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Lactase Market is predicted to reach 403.58 million by 2034 with a CAGR of 5.33%.

Lactase is an enzyme present in the stomachs of humans and other animals that splits lactose into glucose and galactose. Lactose is found in milk products, and lactase aids in its breakdown. Some populations are unable to digest the lactose found in milk products due to a lack of lactase enzymes. To address this issue, lactase is added to dairy products or lactase supplements are supplied so that lactose can be broken down before to intake.

Restraints: Many people are lactose intolerant, which prevents them from drinking milk and dairy products. Lactose-free milk is available, however it is more expensive than regular milk. There have been several ways studied for lowering lactose in milk and dairy products. Lactose-free products are more expensive because the lactose hydrolysis process adds costs. Small and medium-sized enterprises can efficiently manage costs despite a lack of resources and capital, as well as implementation experience.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Source, By Application, By Form.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered Mitushi Biopharma, Rajvi Enterprise, Infinita Biotech Private Limited, Aumgene Biosciences, DuPont, Antozyme Biotech Pvt Ltd, Novact Corporation, Biolaxi Corporation, Creative Enzymes, Nature BioScience Pvt. L.T.D, ENMEX, Advanced Enzyme Technologies, Amano Enzyme Inc, Senson, Merck KGaA.

Lactase Market Segmentation:

By Source: Based on the Source, Global Lactase Market is segmented as; Fungi, Yeast, Bacteria.

By Application: Based on the Application, Global Lactase Market is segmented as; Food & Beverages, Dietary Supplements, Pharmaceuticals.

By Form: Based on the Form, Global Lactase Market is segmented as; Powder, Liquid.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPERs internal database
  • 2.1.4. Premium insight from KOLs
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTERs Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Lactase Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Lactase Market

7. Global Lactase Market, By Source (USD Million) 2021-2034

• 7.1. Fungi
• 7.2. Yeast
• 7.3. Bacteria

8. Global Lactase Market, By Application (USD Million) 2021-2034

• 8.1. Food & Beverages
  • 8.1.1. Milk
  • 8.1.2. Cheese
  • 8.1.3. Yogurt
  • 8.1.4. Others
• 8.2. Dietary Supplements
• 8.3. Pharmaceuticals

9. Global Lactase Market, By Form (USD Million) 2021-2034

• 9.1. Powder
• 9.2. Liquid

10. Global Lactase Market, (USD Million) 2021-2034

• 10.1. Global Lactase Market Size and Market Share

11. Global Lactase Market, By Region, (USD Million) 2021-2034

• 11.1. Asia-Pacific
  • 11.1.1. Australia
  • 11.1.2. China
  • 11.1.3. India
  • 11.1.4. Japan
  • 11.1.5. South Korea
  • 11.1.6. Rest of Asia-Pacific
• 11.2. Europe
  • 11.2.1. France
  • 11.2.2. Germany
  • 11.2.3. Italy
  • 11.2.4. Spain
  • 11.2.5. United Kingdom
  • 11.2.6. Rest of Europe
• 11.3. Middle East and Africa
  • 11.3.1. Kingdom of Saudi Arabia
  • 11.3.2. United Arab Emirates
  • 11.3.3. Qatar
  • 11.3.4. South Africa
  • 11.3.5. Egypt
  • 11.3.6. Morocco
  • 11.3.7. Nigeria
  • 11.3.8. Rest of Middle-East and Africa
• 11.4. North America
  • 11.4.1. Canada
  • 11.4.2. Mexico
  • 11.4.3. United States
• 11.5. Latin America
  • 11.5.1. Argentina
  • 11.5.2. Brazil
  • 11.5.3. Rest of Latin America

12. Company Profile

• 12.1. Mitushi Biopharma
  • 12.1.1. Company details
  • 12.1.2. Financial outlook
  • 12.1.3. Product summary
  • 12.1.4. Recent developments
• 12.2. Rajvi Enterprise
  • 12.2.1. Company details
  • 12.2.2. Financial outlook
  • 12.2.3. Product summary
  • 12.2.4. Recent developments
• 12.3. Infinita Biotech Pvt. Ltd
  • 12.3.1. Company details
  • 12.3.2. Financial outlook
  • 12.3.3. Product summary
  • 12.3.4. Recent developments
• 12.4. Aumgene Biosciences
  • 12.4.1. Company details
  • 12.4.2. Financial outlook
  • 12.4.3. Product summary
  • 12.4.4. Recent developments
• 12.5. DuPont
  • 12.5.1. Company details
  • 12.5.2. Financial outlook
  • 12.5.3. Product summary
  • 12.5.4. Recent developments
• 12.6. Antozyme Biotech Pvt. Ltd
  • 12.6.1. Company details
  • 12.6.2. Financial outlook
  • 12.6.3. Product summary
  • 12.6.4. Recent developments
• 12.7. Novact Corp
  • 12.7.1. Company details
  • 12.7.2. Financial outlook
  • 12.7.3. Product summary
  • 12.7.4. Recent developments
• 12.8. Biolaxi Corp
  • 12.8.1. Company details
  • 12.8.2. Financial outlook
  • 12.8.3. Product summary
  • 12.8.4. Recent developments
• 12.9. Creative Enzymes
  • 12.9.1. Company details
  • 12.9.2. Financial outlook
  • 12.9.3. Product summary
  • 12.9.4. Recent developments
• 12.10. Nature BioScience Pvt. Ltd
  • 12.10.1. Company details
  • 12.10.2. Financial outlook
  • 12.10.3. Product summary
  • 12.10.4. Recent developments
• 12.11. ENMEX
  • 12.11.1. Company details
  • 12.11.2. Financial outlook
  • 12.11.3. Product summary
  • 12.11.4. Recent developments
• 12.12. Advanced Enzyme Technologies
  • 12.12.1. Company details
  • 12.12.2. Financial outlook
  • 12.12.3. Product summary
  • 12.12.4. Recent developments
• 12.13. Amano Enzyme Inc
  • 12.13.1. Company details
  • 12.13.2. Financial outlook
  • 12.13.3. Product summary
  • 12.13.4. Recent developments
• 12.14. Senson
  • 12.14.1. Company details
  • 12.14.2. Financial outlook
  • 12.14.3. Product summary
  • 12.14.4. Recent developments
• 12.15. Merck KGaA
  • 12.15.1. Company details
  • 12.15.2. Financial outlook
  • 12.15.3. Product summary
  • 12.15.4. Recent developments
• 12.16. Others

13. Conclusion

14. List of Abbreviations

15. Reference Links